Clinical Trials Browser

Phase 2 × Multiple Myeloma × pasireotide × Clear all

NCT01329289 2016-02-12

SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma